These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 24801563)
1. Effect of metformin on the incidence of head and neck cancer in diabetics. Yen YC; Lin C; Lin SW; Lin YS; Weng SF Head Neck; 2015 Sep; 37(9):1268-73. PubMed ID: 24801563 [TBL] [Abstract][Full Text] [Related]
2. Risk of head and neck cancer in patients with diabetes mellitus: a retrospective cohort study in Taiwan. Tseng KS; Lin C; Lin YS; Weng SF JAMA Otolaryngol Head Neck Surg; 2014 Aug; 140(8):746-53. PubMed ID: 25058016 [TBL] [Abstract][Full Text] [Related]
3. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer. Yung KC; Piccirillo JF Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348 [TBL] [Abstract][Full Text] [Related]
4. Insulin use increases risk of asthma but metformin use reduces the risk in patients with diabetes in a Taiwanese population cohort. Chen CZ; Hsu CH; Li CY; Hsiue TR J Asthma; 2017 Dec; 54(10):1019-1025. PubMed ID: 28135899 [TBL] [Abstract][Full Text] [Related]
5. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245 [TBL] [Abstract][Full Text] [Related]
6. Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset. Stokes WA; Eguchi M; Amini A; Hararah MK; Ding D; McDermott JD; Bradley CJ; Karam SD Oral Oncol; 2018 Sep; 84():12-19. PubMed ID: 30115470 [TBL] [Abstract][Full Text] [Related]
7. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK. Kowall B; Stang A; Rathmann W; Kostev K Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313 [TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus, metformin and head and neck cancer. Figueiredo RA; Weiderpass E; Tajara EH; Ström P; Carvalho AL; de Carvalho MB; Kanda JL; Moyses RA; Wünsch-Filho V Oral Oncol; 2016 Oct; 61():47-54. PubMed ID: 27688104 [TBL] [Abstract][Full Text] [Related]
9. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer. Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906 [TBL] [Abstract][Full Text] [Related]
10. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status. Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414 [TBL] [Abstract][Full Text] [Related]
11. Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus. Hung YC; Lin CC; Wang TY; Chang MP; Sung FC; Chen CC Diabetes Metab Res Rev; 2013 Nov; 29(8):673-9. PubMed ID: 23956007 [TBL] [Abstract][Full Text] [Related]
13. The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study. Spratt DE; Beadle BM; Zumsteg ZS; Rivera A; Skinner HD; Osborne JR; Garden AS; Lee NY Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):523-531. PubMed ID: 26867881 [TBL] [Abstract][Full Text] [Related]
14. Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study. Cheng YY; Leu HB; Chen TJ; Chen CL; Kuo CH; Lee SD; Kao CL J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e99-105. PubMed ID: 24119365 [TBL] [Abstract][Full Text] [Related]
15. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts. Al Hilli MM; Bakkum-Gamez JN; Mariani A; Cliby WA; Mc Gree ME; Weaver AL; Dowdy SC; Podratz KC Gynecol Oncol; 2016 Feb; 140(2):270-6. PubMed ID: 26607780 [TBL] [Abstract][Full Text] [Related]
16. Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan. Lai SW; Liao KF; Chen PC; Tsai PY; Hsieh DP; Chen CC Clin Lung Cancer; 2012 Mar; 13(2):143-8. PubMed ID: 22129971 [TBL] [Abstract][Full Text] [Related]
17. Effect of pioglitazone medication on the incidence of dementia. Heneka MT; Fink A; Doblhammer G Ann Neurol; 2015 Aug; 78(2):284-94. PubMed ID: 25974006 [TBL] [Abstract][Full Text] [Related]
18. Increased risk of urinary tract calculi among patients with diabetes mellitus--a population-based cohort study. Chen HS; Su LT; Lin SZ; Sung FC; Ko MC; Li CY Urology; 2012 Jan; 79(1):86-92. PubMed ID: 22119251 [TBL] [Abstract][Full Text] [Related]
19. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes. Tseng CH Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842 [TBL] [Abstract][Full Text] [Related]
20. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus. Tseng CH Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]